Atlas Trials

Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency

Clinical trial NCT00927602 · TERMINATED

Trial details

NCT number
NCT00927602
Sponsor
Università degli Studi dell'Insubria
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Medical PatientsRenal Insufficiency
Start date
2009-04-01
Primary completion
2011-12-01
Enrollment
206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.